Evaluation of Biocoat® intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity

被引：87

作者：

Chong, SH ^{[1
]}

Dando, SA ^{[1
]}

Morrison, RA ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA

来源：

PHARMACEUTICAL RESEARCH | 1997年 / 14卷 / 12期

关键词：

Biocoat (R) intestinal epithelium differentiation environment; in vitro epithelial model; Caco-2; cells;

D O I：

10.1023/A:1012112820371

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：1835 / 1837

页数：3

共 17 条

[1] CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
ARTURSSON, P
KARLSSON, J
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) : 880 - 885
[2] PHARMACOKINETIC EVALUATION IN MAN OF TERBUTALINE GIVEN AS SEPARATE ENANTIOMERS AND AS THE RACEMATE
BORGSTROM, L
NYBERG, L
JONSSON, S
LINDBERG, C
PAULSON, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (01) : 49 - 56
[3] In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system
Chong, SH
Dando, SA
Soucek, KM
Morrison, RA
[J]. PHARMACEUTICAL RESEARCH, 1996, 13 (01) : 120 - 123
[4] Comparison of HT29-18-C-1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption
Collett, A
Sims, E
Walker, D
He, YL
Ayrton, J
Rowland, M
Warhurst, G
[J]. PHARMACEUTICAL RESEARCH, 1996, 13 (02) : 216 - 221
[5] COLLINS RF, 1976, BRIT J CLIN PHARMACO, V3, pP346
[6] DREYFUSS J, 1977, J CLIN PHARM MAY, P300
[7] Everett Donald W., 1992, Pharmaceutical Research (New York), V9, pS316
[8] CLINICAL PHARMACOKINETICS OF PARACETAMOL
FORREST, JAH
CLEMENTS, JA
PRESCOTT, LF
[J]. CLINICAL PHARMACOKINETICS, 1982, 7 (02) : 93 - 107
[9] Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
Lo, MW
Goldberg, MR
McCrea, JB
Lu, H
Furtek, CI
Bjornsson, TD
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) : 641 - 649
[10] MARKS V, 1973, LANCET, V1, P827

← 1 2 →